Weekly intelligence on first-in-human, Phase 1, and early-feasibility clinical trials across Latin America. Covering ANMAT (Argentina), ANVISA (Brazil), INVIMA (Colombia), COFEPRIS (Mexico), ISP (Chile), AGEMED (Bolivia), and the regional clinical trial regulators reshaping how sponsors run early-phase studies.